Biomarkers & Diagnostics for Complex & Rare Diseases - Track C: CDx Development & Commercialization

Skip to content

31633 - 13th World Clinical Biomarkers & CDx Boston 2023 (2)

Supercharge Co-Development of Therapeutics & Companion Diagnostics

Returning September 3 - 6, 2024 | Boston, MA

Get updates for the 2024 meeting

View upcoming events in the Precision Oncology Series

Home
About
- About 2023 Event
- Hanson Wade
What’s On
- 2023 Full Event Guide
- 2023 Expert Speakers
Partnership
- Partnership Opportunities
- 2023 Partners
Take Part
- Register Interest
- Contact us

Track C: CDx Development & Commercialization

Time: 10:45 am
day: Day 1 Track C AM

Speakers:

Kristina McGuire

Kristina McGuire

VENUE

Omni Boston Hotel at the Seaport
450 Summer Street
Boston, MA, 02210

LOCATION

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences	Beacon
Searchlight	Intelligence

SEARCH

Search

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

HWG

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok